Buscar
Danaher Corp
DHR196.200USD
+5.190+2.72%
Cierre 04/08, 16:00（ET）Cotizaciones retrasadas 15 min
135.92BCap. mercado
38.69P/E TTM
Más Datos de Danaher Corp Compañía
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Información de Danaher Corp
Símbolo de cotizaciónDHR
Nombre de la empresaDanaher Corp
Fecha de salida a bolsaJan 16, 2106
Director ejecutivoBlair (Rainer M)
Número de empleados61000
Tipo de seguridadOrdinary Share
Fin del año fiscalJan 16
Dirección2200 Pennsylvania Ave NW Ste 800W
CiudadWASHINGTON
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal20037-1701
Teléfono12028280850
Sitio Webhttps://www.danaher.com/
Símbolo de cotizaciónDHR
Fecha de salida a bolsaJan 16, 2106
Director ejecutivoBlair (Rainer M)
Ejecutivos de Danaher Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Steven M. Rales
Mr. Steven M. Rales
Chairman of the Board
Chairman of the Board
42.24M
+0.00%
Mr. Mitchell P. Rales
Mr. Mitchell P. Rales
Director
Director
33.00M
-2.71%
Mr. Rainer M. Blair
Mr. Rainer M. Blair
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
87.51K
+46.00%
Mr. Alan G. Spoon, J.D.
Mr. Alan G. Spoon, J.D.
Independent Director
Independent Director
84.94K
-0.68%
Mr. John T. Schwieters
Mr. John T. Schwieters
Independent Director
Independent Director
40.96K
-1.41%
Mr. Brian W. Ellis
Mr. Brian W. Ellis
Senior Vice President
Senior Vice President
22.97K
+1.92%
Dr. Elias A. Zerhouni, M.D.
Dr. Elias A. Zerhouni, M.D.
Independent Director
Independent Director
16.44K
+1.51%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Senior Vice President - Corporate Development
Senior Vice President - Corporate Development
16.02K
-29.35%
Dr. Jose-Carlos Gutierrez-Ramos, Ph.D.
Dr. Jose-Carlos Gutierrez-Ramos, Ph.D.
Senior Vice President, Chief Science Officer
Senior Vice President, Chief Science Officer
9.53K
+34.79%
Mr. Greg Milosevich
Mr. Greg Milosevich
Executive Vice President
Executive Vice President
9.06K
+45.84%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Steven M. Rales
Mr. Steven M. Rales
Chairman of the Board
Chairman of the Board
42.24M
+0.00%
Mr. Mitchell P. Rales
Mr. Mitchell P. Rales
Director
Director
33.00M
-2.71%
Mr. Rainer M. Blair
Mr. Rainer M. Blair
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
87.51K
+46.00%
Mr. Alan G. Spoon, J.D.
Mr. Alan G. Spoon, J.D.
Independent Director
Independent Director
84.94K
-0.68%
Mr. John T. Schwieters
Mr. John T. Schwieters
Independent Director
Independent Director
40.96K
-1.41%
Mr. Brian W. Ellis
Mr. Brian W. Ellis
Senior Vice President
Senior Vice President
22.97K
+1.92%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de abr
Divisa: USDActualizado: lun., 6 de abr
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
All Other
11.96B
48.66%
United States
9.98B
40.63%
China
2.63B
10.71%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.
Estadísticas de accionistas
Actualizado: sáb., 21 de feb
Actualizado: sáb., 21 de feb
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
8.57%
Rales (Steven M)
5.97%
Rales (Mitchell P)
4.66%
BlackRock Institutional Trust Company, N.A.
4.12%
State Street Investment Management (US)
3.91%
Otro
72.76%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
8.57%
Rales (Steven M)
5.97%
Rales (Mitchell P)
4.66%
BlackRock Institutional Trust Company, N.A.
4.12%
State Street Investment Management (US)
3.91%
Otro
72.76%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
46.58%
Investment Advisor/Hedge Fund
25.95%
Individual Investor
10.69%
Hedge Fund
2.99%
Research Firm
2.48%
Pension Fund
2.45%
Bank and Trust
2.07%
Sovereign Wealth Fund
1.44%
Family Office
0.35%
Otro
5.00%
Participación institucional
Actualizado: mié., 1 de abr
Actualizado: mié., 1 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q1
3896
596.10M
84.23%
-312.00K
2025Q4
3713
600.67M
84.70%
+80.00
2025Q3
3823
600.80M
83.72%
+9.92M
2025Q2
3884
590.58M
83.08%
+3.57M
2025Q1
3906
588.12M
83.05%
-6.10M
2024Q4
3917
584.70M
83.45%
-1.93M
2024Q3
3784
586.76M
84.40%
-9.93M
2024Q2
3730
596.69M
83.29%
-8.16M
2024Q1
3735
604.73M
82.65%
-7.38M
2023Q4
3745
604.00M
82.08%
+5.49M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
60.67M
8.57%
+81.50K
+0.13%
Dec 31, 2025
Rales (Steven M)
42.24M
5.97%
+352.00
+0.00%
Mar 01, 2026
Rales (Mitchell P)
33.00M
4.66%
-894.31K
-2.64%
Mar 01, 2026
BlackRock Institutional Trust Company, N.A.
29.18M
4.12%
+81.25K
+0.28%
Dec 31, 2025
State Street Investment Management (US)
27.68M
3.91%
+472.61K
+1.74%
Dec 31, 2025
Capital International Investors
18.25M
2.58%
+1.49M
+8.88%
Dec 31, 2025
Fidelity Management & Research Company LLC
17.42M
2.46%
+3.85M
+28.35%
Dec 31, 2025
Wellington Management Company, LLP
15.08M
2.13%
+1.52M
+11.19%
Dec 31, 2025
T. Rowe Price Associates, Inc.
15.04M
2.13%
+1.37M
+10.00%
Dec 31, 2025
Geode Capital Management, L.L.C.
13.77M
1.95%
-74.97K
-0.54%
Dec 31, 2025
Ver más
ETFs relacionados
Actualizado: mié., 5 de nov
Actualizado: mié., 5 de nov
Nombre
Proporción
Parnassus Core Select ETF
6.32%
VanEck Morningstar Wide Moat Value ETF
4.47%
iShares ESG Aware MSCI USA Value ETF
3.95%
Macquarie Focused Large Growth ETF
3.91%
Monarch Blue Chips Core ETF
3.82%
Eagle Capital Select Equity ETF
3.63%
Madison Covered Call ETF
3.37%
iREIT MarketVector Quality REIT Index ETF
3.35%
JPMorgan Healthcare Leaders ETF
3.23%
FMC Excelsior Focus Equity ETF
3.13%
Ver más
Parnassus Core Select ETF
Proporción6.32%
VanEck Morningstar Wide Moat Value ETF
Proporción4.47%
iShares ESG Aware MSCI USA Value ETF
Proporción3.95%
Macquarie Focused Large Growth ETF
Proporción3.91%
Monarch Blue Chips Core ETF
Proporción3.82%
Eagle Capital Select Equity ETF
Proporción3.63%
Madison Covered Call ETF
Proporción3.37%
iREIT MarketVector Quality REIT Index ETF
Proporción3.35%
JPMorgan Healthcare Leaders ETF
Proporción3.23%
FMC Excelsior Focus Equity ETF
Proporción3.13%
Dividendos
Un total de
3.15B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Feb 24, 2026
DHR.NB Interim Cash Dividend of gross USD 0.4 paid on Apr 24, 2026 going ex on Mar 27, 2026
Mar 27, 2026
Apr 24, 2026
Mar 27, 2026
Dec 09, 2025
DHR.NB Final Cash Dividend of gross USD 0.32 paid on Jan 30, 2026 going ex on Dec 26, 2025
Dec 26, 2025
Jan 30, 2026
Dec 26, 2025
Sep 09, 2025
DHR.NB Final Cash Dividend of gross USD 0.32 paid on Oct 31, 2025 going ex on Sep 26, 2025
Sep 26, 2025
Oct 31, 2025
Sep 26, 2025
May 06, 2025
DHR.NB Interim Cash Dividend of gross USD 0.32 paid on Jul 25, 2025 going ex on Jun 27, 2025
Jun 27, 2025
Jul 25, 2025
Jun 27, 2025
Feb 20, 2025
DHR.NB Interim Cash Dividend of gross USD 0.32 paid on Apr 25, 2025 going ex on Mar 28, 2025
Mar 28, 2025
Apr 25, 2025
Mar 28, 2025
Dec 10, 2024
DHR.NB Interim Cash Dividend of gross USD 0.27 paid on Jan 31, 2025 going ex on Dec 27, 2024
Dec 27, 2024
Jan 31, 2025
Dec 27, 2024
Sep 10, 2024
DHR.NB Final Cash Dividend of gross USD 0.27 paid on Oct 25, 2024 going ex on Sep 27, 2024
Sep 27, 2024
Oct 25, 2024
Sep 27, 2024
May 07, 2024
DHR.NB Interim Cash Dividend of gross USD 0.27 paid on Jul 26, 2024 going ex on Jun 28, 2024
Jun 28, 2024
Jul 26, 2024
Jun 28, 2024
Feb 21, 2024
DHR.NB Interim Cash Dividend of gross USD 0.27 paid on Apr 26, 2024 going ex on Mar 27, 2024
Mar 28, 2024
Apr 26, 2024
Mar 27, 2024
Dec 05, 2023
DHR.NB Interim Cash Dividend of gross USD 0.24 paid on Jan 26, 2024 going ex on Dec 28, 2023
Dec 29, 2023
Jan 26, 2024
Dec 28, 2023
Ver más
División de acciones
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
